Cubist Systematic Strategies, LLC Concert Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $116,750 - $157,101	-26,901 Reduced 36.82%	46,167 $269,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $72,824 - $122,796	-17,055 Reduced 18.92%	73,068 $490,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $252,344 - $573,182	90,123 New	90,123 $379,000
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $33,453 - $48,280	-12,254 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $32,963 - $51,711	12,254 New	12,254 $39,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $39,472 - $51,675	-12,452 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $96,885 - $134,662	-25,699 Reduced 67.36%	12,452 $53,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $178,119 - $479,015	36,650 Added 2441.71%	38,151 $190,000
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $12,475 - $16,897	-1,316 Reduced 46.72%	1,501 $19,000
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $23,617 - $29,473	2,724 Added 2929.03%	2,817 $28,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $725 - $1,071	93 New	93 $1,000
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $107,221 - $225,202	-18,235 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $71,394 - $99,226	7,563 Added 70.87%	18,235 $219,000
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $128,811 - $187,186	10,672 New	10,672 $129,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $352,553 - $513,621	-18,324 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $189,786 - $394,934	13,595 Added 287.48%	18,324 $474,000
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $65,780 - $72,400	4,729	4,729 $70,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.